About Us

Who are Satipharm?
A Health and Wellness Company

Satipharm is a health and wellness company which is specialised in the development and manufacture of cannabinoid-based products from the cannabis plant. Our focus is on becoming the global leader in the cannabis market by delivering the highest quality products that are designed specifically with the needs of our customers in mind. 

Company History

Based in Vancouver, our parent company Harvest One was established in 2013 and was one of the first Canadian licenced producers of cannabis. Harvest One is a listed company that is governed by the rules and regulations of the Toronto Stock Exchange.

In 2015, Satipharm was established as the medicinal and wellbeing division of Harvest One. Since then, we have been providing products of exceptional quality that are manufactured in a regulated and safe environment to Good Manufacturing Practice standards (GMP).

2018 saw the establishment of Satipharm’s global head office in Dublin, Ireland. The new management team brings a blend of highly experienced people from the pharmaceutical, consumer goods, life sciences and financial management sectors.

In 2019 Satipharm CBD 10mg Gelpell® capsules were made readily available in many European countries, marking a significant milestone of product and company development coming to fruition.  

Brand Vision

At Satipharm, we are focused on supporting people in living richer, more fulfilled lives. We do this by manufacturing products of the highest quality and providing educational resources to our patients and customers.

Manufacturing Standards (GMP)

Our manufacturing process is in line with the international standards of Good Manufacturing Practice (GMP). This ensures that Satipharm only provides products of exceptional, consistent quality, that are manufactured in a regulated, safe environment.

Learn more about Satipharm and our CBD Gelpell® technology.

 

 

 GMP Good Manufacturing PracticesISO 22000ISO 12485Council of Europe - Good Agricultural Collecting Practices